Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion type Assertion NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_head.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion description "[In conclusion, our data, for the first time, demonstrate that MCT1 inhibition has antitumor potential which is associated with the NF-?B pathway, and high MCT1 expression predicates poor overall survival in patients with osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_provenance.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion evidence source_evidence_literature NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_provenance.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion SIO_000772 24012639 NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_provenance.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion wasDerivedFrom befree-20150227 NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_provenance.
- NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_assertion wasGeneratedBy ECO_0000203 NP316353.RAoVJBbFkV21Ho0KAAZD0yUIr2Q4-hm9cIp7nBmYYuYzY130_provenance.